Patent directory · USPTO A61K / A61P
Patents matching “Aldeyra Therapeutics, Inc.”
38 pharma patents match "Aldeyra Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 38 pharmaceutical patents matching "Aldeyra Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12240816
Deuterated compounds and uses thereof
granted -
US 12128013
Toxic aldehyde related diseases and treatment
granted -
US 12097188
Compositions and methods for the treatment of macular degeneration
granted -
US 12064516
Pharmaceutical formulations and uses thereof
granted -
US 12029735
Polymorphic compounds and uses thereof
granted -
US 12005061
Ophthalmic formulations of methotrexate
granted -
US 12005060
Ophthalmic formulations of methotrexate
granted -
US 12006298
Polymorphic compounds and uses thereof
granted -
US 11911385
Methotrexate treatment methods
granted -
US 11845722
Deuterated compounds and uses thereof
granted -
US 11786518
Ophthalmic formulations and uses thereof
granted -
US 11771664
Toxic aldehyde related diseases and treatment
granted -
US 11724987
Compositions and methods of treating retinal disease
granted -
US 11701331
Toxic aldehyde related diseases and treatment
granted -
US 11583529
Treatment of inflammatory disorders
granted -
US 11459300
Deuterated compounds and uses thereof
granted -
US 11312692
Polymorphic compounds and uses thereof
granted -
US 11197821
Formulations for treatment of dry eye disease
granted -
US 11129823
Combination treatment of ocular inflammatory disorders and diseases
granted -
US 11046650
Deuterated compounds and uses thereof
granted -
US 11040039
Treatment of inflammatory disorders
granted -
US 11007157
Toxic aldehyde related diseases and treatment
granted -
US 10913722
Compositions and methods of treating retinal disease
granted -
US 10588874
Toxic aldehyde related diseases and treatment
granted